Republic Day Sale

Dr. Reddy's Laboratories Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1984

Chairman: K Satish Reddy

Managing Director: GV Prasad

Group: Dr. Reddy's

Listing: NSE: DRREDDY, BSE: 500124

Headquarters: Hyderabad, Telangana

Website: www.drreddys.com

Key Facts

Market cap: R 50,315.03 Cr

Revenue (TTM): R 16,565.20 Cr

Earnings (TTM): R 2,686.40 Cr

Cash: R 2,475.70 Cr

Total Debt: R 3,838.10 Cr

Promoters' ownership: 26.76%

Liquidity: High

52 Week range: R 1,872.95 - 3,105.05

Face value: R5.00

Shares outstanding: 16,61,63,148

Stock Performance

Trailing
Annual

Time Period	Dr. Reddy's Lab	*	*
YTD	5.46	--	--
1 month	4.68	--	--
3 months	7.29	--	--
1 Year	13.60	--	--
3 Years	0.65	--	--
5 Years	-1.97	--	--
10 Years	10.38	--	--

As on 24-Jan-2020 *As on

Year	Dr. Reddy's Lab	S&P BSE Sensex	S&P BSE Healthcare
2019	10.26	14.38	-3.55
2018	8.33	5.87	-5.89
2017	-21.11	27.91	0.49
2016	-1.55	1.95	-12.88
2015	-3.17	-5.03	15.06
2014	27.93	29.89	47.43
2013	38.07	8.98	22.55

Annual Report (FY18)

Review & Analysis

A hunt for quality large caps available cheap
Jugal Harpalani . 09-Oct-2019
Fall of Pharma
Mohammed Ekramul Haque . 13-Oct-2016
Giants fall too
Research Desk . 19-Sep-2016
Who wins in India: Value or Growth?
Kumar Shankar Roy . 15-Jul-2016
Dr Reddy's set to complete remediation work, to seek USFDA re-inspection soon
Viswanath Pilla . 06-Jul-2016

News & Announcements

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
22-Jan-2020
Shareholding for the Period Ended December 31 2019
18-Jan-2020
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
17-Jan-2020
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
17-Jan-2020
Statement Of Investor Complaints For The Quarter Ended December 2019
13-Jan-2020